Pedro T Ramirez Selected Research

Cytoreduction Surgical Procedures

12/2023	Cardiophrenic lymph nodes in advanced ovarian cancer.
9/2023	Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods.
1/2023	Secondary validation of an ovarian cancer-specific comorbidity index in a US population.
12/2022	Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative).
12/2021	Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer.
6/2015	Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.
4/2015	A framework for a personalized surgical approach to ovarian cancer.
1/2015	The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer.
7/2011	Preoperative factors predicting survival after secondary cytoreduction for recurrent ovarian cancer.
4/2010	Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro T Ramirez Research Topics

Disease

84	Neoplasms (Cancer) 02/2024 - 05/2002
76	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2024 - 04/2006
27	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 08/2004
25	Endometrial Neoplasms (Endometrial Cancer) 11/2023 - 08/2004
20	Carcinoma (Carcinomatosis) 01/2020 - 04/2004
14	Ovarian Epithelial Carcinoma 09/2023 - 08/2004
14	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2004
10	Adenocarcinoma 01/2023 - 10/2004
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 11/2018
6	Wounds and Injuries (Trauma) 01/2021 - 10/2003
5	Adenosquamous Carcinoma 01/2023 - 12/2007
5	Uterine Neoplasms (Uterine Cancer) 01/2018 - 09/2004
5	Intraoperative Complications 09/2015 - 10/2008
4	Pain (Aches) 01/2021 - 04/2013
4	Disease Progression 01/2017 - 07/2008
3	Venous Thromboembolism 01/2023 - 10/2010
3	Vulvar Neoplasms (Vulvar Cancer) 01/2021 - 09/2003
3	Nausea 01/2019 - 01/2008
3	Fatigue 01/2019 - 01/2008
3	Hyperplasia 01/2018 - 10/2004
3	Hypertension (High Blood Pressure) 01/2017 - 11/2011
3	Fallopian Tube Neoplasms 10/2015 - 12/2006
3	Lymphatic Metastasis 12/2014 - 08/2010
3	Residual Neoplasm 03/2010 - 10/2008
2	Neoplasm Micrometastasis 11/2023 - 12/2010
2	Choriocarcinoma 10/2023 - 04/2009
2	Margins of Excision 10/2023 - 08/2006
2	Carcinosarcoma 01/2023 - 04/2011
2	Peritoneal Neoplasms 12/2022 - 07/2005
2	Leiomyosarcoma 12/2016 - 02/2015
2	Pathologic Constriction (Stenosis) 01/2016 - 06/2013
2	Small Cell Carcinoma 01/2015 - 01/2012
2	Female Genital Diseases 11/2013 - 09/2011
2	Fistula 06/2013 - 10/2004
2	Overweight 05/2012 - 10/2008
2	Lymphadenopathy 07/2011 - 12/2010
1	Communicable Diseases (Infectious Diseases) 09/2023
1	Disease Resistance 01/2023
1	Urinary Tract Infections (Urinary Tract Infection) 07/2022
1	Acute Kidney Injury (Acute Renal Failure) 10/2021

Drug/Important Bio-Agent (IBA)

9	PlatinumIBA 04/2015 - 08/2004
5	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 04/2006
5	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 11/2007
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 02/2024 - 02/2016
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 08/2004
4	taxaneIBA 04/2015 - 01/2008
3	Opioid Analgesics (Opioids)IBA 01/2021 - 04/2013
2	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2021 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 04/2013
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019 - 10/2015
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2014 - 09/2008
2	liposomal doxorubicin (Doxil)FDA Link 01/2013 - 03/2010
2	Coloring Agents (Dyes)IBA 12/2012 - 01/2004
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2012 - 11/2007
2	Etoposide (VP 16)FDA LinkGeneric 01/2012 - 11/2007
2	CytokinesIBA 05/2009 - 04/2006
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2009 - 04/2006
2	Carcinoembryonic AntigenIBA 04/2009 - 06/2005
2	Keratin-7 (Cytokeratin 7)IBA 06/2005 - 09/2004
2	Keratin-20 (Cytokeratin 20)IBA 06/2005 - 09/2004
1	ParaffinIBA 11/2023
1	Pyridinolcarbamate (P23)IBA 01/2023
1	pembrolizumabIBA 01/2023
1	lenvatinibIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023

Therapy/Procedure

63	Hysterectomy 02/2024 - 01/2004
46	Lymph Node Excision (Lymph Node Dissection) 11/2023 - 09/2003
31	Therapeutics 11/2023 - 02/2004
27	Trachelectomy 02/2024 - 09/2008
26	Drug Therapy (Chemotherapy) 02/2024 - 08/2004
18	Laparotomy 01/2023 - 08/2002
17	Minimally Invasive Surgical Procedures 11/2023 - 10/2010
17	Radiotherapy 01/2023 - 02/2004
15	Length of Stay 07/2022 - 08/2006
12	Neoadjuvant Therapy 10/2023 - 03/2008
10	Cytoreduction Surgical Procedures 12/2023 - 04/2010
9	Conservative Treatment 01/2022 - 01/2004
7	Salpingo-oophorectomy 12/2021 - 09/2004
6	Gynecologic Surgical Procedures (Gynecologic Surgery) 01/2023 - 05/2012
6	Pelvic Exenteration 09/2018 - 12/2009
6	Operative Time 12/2014 - 07/2007
5	Blood Transfusion (Blood Transfusions) 09/2023 - 08/2006
5	Enhanced Recovery After Surgery 01/2023 - 01/2019
3	Surgical Instruments (Clip) 02/2024 - 07/2011
3	Catheters 07/2022 - 08/2004
2	Hyperthermic Intraperitoneal Chemotherapy 03/2024 - 09/2023
2	Adjuvant Radiotherapy 02/2024 - 09/2008
2	Urinary Diversion (Ileal Conduit) 06/2013 - 05/2002
2	Robotic Surgical Procedures 09/2011 - 03/2009
2	Colostomy 11/2008 - 10/2008
2	Cystotomy 10/2008 - 08/2006
2	Splenectomy 01/2008 - 02/2007
2	Appendectomy 12/2006 - 03/2005
2	Vulvectomy 02/2004 - 01/2004
1	Patient Readmission 09/2023
1	Investigational Therapies (Experimental Therapy) 02/2023
1	Immunotherapy 01/2023
1	Precision Medicine 01/2023
1	Urinary Catheters 07/2022